The first steps towards developing a vaccine against an insidious sexual transmitted infection (STI) have been accomplished by researchers at McMaster University.
Researchers at the Michael G. DeGroote Institute for Infectious Disease Research at McMaster have developed the first widely protective vaccine against chlamydia, a common STI that is mostly asymptomatic but impacts 113 million people around the world each year and can result in infertility.
In a study, recently published in the journal Vaccine, the researchers show that a novel chlamydial antigen known as BD584 is a potential vaccine candidate for the most common species of chlamydia known as Chlamydia trachomatis.
As most C. trachomatis infections are asymptomatic, chlamydia can often go untreated and lead to upper genital tract infections, pelvic inflammatory disease, and infertility. This is why the promise of a vaccine would be extremely beneficial, says David Bulir, co-author of the study.
“Vaccine development efforts in the past three decades have been unproductive and there is no vaccine approved for use in humans,” said Bulir, who just finished his PhD in medical sciences at McMaster.
“Vaccination would be the best way to way to prevent a chlamydia infection, and this study has identified important new antigens which could be used as part of a vaccine to prevent or eliminate the damaging reproductive consequences of untreated infections.”
In the research team’s study, BD584 was able to reduce chlamydial shedding – a symptom of C. trachomatis – by 95 per cent. The antigen also decreased hydrosalpinx, another C. trachomatis symptom which involves fallopian tubes being blocked with serous fluids, by 87.5 per cent.
The results look very promising, said senior author James Mahony, a professor of Pathology and Molecular Medicine for McMaster’s Michael G. DeGroote School of Medicine and a researcher at St. Joseph Healthcare Hamilton’s Research Institute where the work was performed.
Co-author and McMaster PhD student, Steven Liang, explains, “not only is the vaccine effective, it also has the potential to be widely protective against all C. trachomatis strains, including those that cause trachoma.”
Trachoma is an eye infection caused by chlamydia and is the leading cause of preventable blindness affecting millions of people in many resource-poor regions of the world.
“The vaccine would be administered through the nose. This is easy and painless and does not require highly trained health professionals to administer, and that makes it an inexpensive solution for developing nations,” he said.
The next step is more testing for effectiveness against different strains of Chlamydia and in different formulations. The study was funded by the Canadian Institutes for Health Research.
The Latest on: Chlamydia
via Google News
The Latest on: Chlamydia
- Why the dramatic rise in sexually transmitted infections is a major wakeup call on April 17, 2019 at 10:56 am
So the question is, why are we seeing this increase?” Given that untreated STIs like chlamydia, gonorrhea, and syphilis can lead to some pretty dire consequences—including infertility, pelvic ... […]
- STDs spreading faster in South Carolina than most of U.S. on April 17, 2019 at 9:01 am
The Palmetto State has one of the highest cases of chlamydia in the nation with 649.8 cases per 100,000 residents. That's compared to the national average of 528.8 cases. South Carolina also ranks ... […]
- STD rates continue to rise on April 16, 2019 at 4:38 am
Common STDs include chlamydia, HPV (human papillomavirus), gonorrhea, genital herpes, HIV and syphilis. “Statistics show that one in two sexually active young people will get an STD by age 25 — and ... […]
- Rethinking STDs on April 15, 2019 at 9:07 pm
My team and I are creating a point-of-care microfluidic device that can process up to 10mL of urine and provide a smartphone-based readout for Chlamydia in under 30 minutes. We call ourselves ... […]
- Chlamydia Infection Test Market Size to Rapid Growth and Forecast till 2025 | Abbott, ADI/American Diagnostica, Agilent Technologies on April 9, 2019 at 8:47 am
The global Chlamydia Infection Test market is brilliantly evaluated in the research study that explores vital aspects such as market competition, segmentation, revenue and production growth, and ... […]
- Alachua County has second highest chlamydia rate in Florida on April 4, 2019 at 10:11 pm
Grab your condoms and dental dams. Alachua County has one of the highest rates of chlamydia in Florida. The county is the second highest, according to a 2019 report by County Health Rankings and ... […]
- STD Trends: Gonorrhea, Chlamydia numbers up in Iowa and nationally on April 4, 2019 at 6:15 am
For the most part, sexually transmitted disease diagnoses in Iowa continue to increase similar to national trends, according to 2018 data from the state Department of Public Health. The one exception ... […]
- Chlamydia Is One of the Most Common STDs - Here's What a Doctor Wants You to Know on April 2, 2019 at 1:07 pm
STDs aren't the kind of thing you generally discuss at the dinner table with your friends. It's a taboo topic that many people feel uncomfortable talking about in any setting, in fact, even with a ... […]
- Leon County has highest chlamydia rate in Florida on March 24, 2019 at 9:03 am
Leon County earned a dubious public health distinction, becoming No. 1 in Florida for new chlamydia infections. The news came via the Robert Wood Johnson Foundation and the University of Wisconsin, ... […]
- Jeremy Kyle Show viewers horrified as guest admits wife cheated on him ten times and gave him chlamydia… but he still loves her on March 20, 2019 at 8:25 am
Guest Shannon was on with her partner Curtis, and was adamant it was her mum who was to blame for her promiscuity Shannon slept with ten men behind partner Curtis' back - and gave him an STD. But he ... […]
via Bing News